October 25, 2005 08:30 ET

Raymor Receives an Order From Wright Medical and Continues its Advance Into the Biomedical Sector With its Spherical Titanium Powder

MONTREAL, QUEBEC--(CCNMatthews - Oct. 25, 2005) - Raymor Industries Inc. (TSX VENTURE:RAR) is proud to announce that its wholly-owned subsidiary, AP&C Advanced Powders and Coatings Inc. (AP&C) has received an order for its spherical titanium powder from Wright Medical Technology, a US-based company specialized in the design, manufacturing and sale of orthopedic implants.

Wright Medical Technology is a global orthopedic medical device company specializing in the design, manufacture, and marketing of reconstructive joint devices and biologics. Wright Medical Technology's product offerings include large joint implants for the hip and knee; extremity implants for the hand, elbow, shoulder, foot and ankle; and both synthetic and tissue-based bone graft substitute materials. Headquartered in Arlington, Tennessee, Wright Medical Technology has been in business for more than 50 years and has approximately 750 employees. Its parent company, Wright Medical Group (NASDAQ: WMGI) earned revenues of US$297 million in 2004 with a net income of US$24 million.

"The biomedical sector is a strategic market that we have been targeting with our spherical titanium powders," said Stephane Robert, President of Raymor Industries. "This order from Wright Medical Technology adds a prominent name to our client list with an important potential for us," adds Mr. Robert.

AP&C's metallic powders are produced using the patented Plasma Atomization Process. This globally unique process produces a highly pure metallic powder with an exceptional sphericity. These two properties allow AP&C's metallic powders to offer the best performance for biomedical applications. The patented Plasma Atomization Process, of which AP&C holds an exclusive, worldwide license, was developed at the beginning of the 90's at Hydro-Quebec's Shawinigan laboratory in collaboration with Noranda.

The world market for orthopedic implants was more than US$6.4 billion in 2002. Analysts from the renowned Freedonia Group predict markets of US$8.7 billion in 2007 and US$11.6 billion in 2012. The overall growth rate for this sector will be 6.2%. However, Freedonia Group and Frost & Sullivan both agree that this growth rate can increase significantly (up to 15% per year), given the potential removal of certain anti-inflammatory and pain medications from the market place by the FDA. As well, an aging population will likely have an impact on the orthopedic implant market growth rate.

RAYMOR INDUSTRIES INC. (TSX VENTURE:RAR) has as its mission to become the leading Canadian developer of high technology and a producer/recycler of advanced materials and nanomaterials for high value-added applications. In November 2004, Raymor Industries created a wholly-owned, industrial subsidiary, AP&C Advanced Powders and Coatings, specializing in nanotechnology and advanced materials, and comprising four operational divisions: (1) nanotechnology products, including nano-powders, nano-coatings, and single-walled carbon nanotubes (C-SWNT) for "the applications of tomorrow"; (2) thermal spray coatings, which largely targets military, aeronautical, aerospace, specialized industrial, and mining applications; (3) spherical metallic powders, primarily used for biomedical and aerospace applications; and (4) net-shape forming, a component manufacturing technique used for ballistic protection and other aerospace and military applications. Raymor holds the exclusive rights to more than 20 patents throughout the world, with other patents pending.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release

Contact Information